AllSight
Companies · AORT · Surgical & Medical Instruments & Apparatus

ARTIVION, INC. (AORT)

ARTIVION, INC. (AORT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

ARTIVION, INC. (AORT) stock — financials & valuation

Key numbers for ARTIVION, INC. (AORT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 41/100 — a percentile rank of ARTIVION, INC.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$1.1B
P / S2.4×
EV / EBITDA36.9×
Gross margin64.4%
Operating margin2.9%
Net margin-0.7%
Return on equity-0.7%
ROIC-2.6%
Revenue growth16.4%
Debt / equity0.8×
Dividend yield0.0%

Is ARTIVION, INC. overvalued? P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from ARTIVION, INC.’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Revenue beat expectations, but EBITDA guidance was cut and profitability deteriorated
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact